logo
Select company
Select metric
-11.92%Return on Equity
VS
Market
33
Sector
72
Industry
88
History
96
$ 9.52Close
$ 6.07 - $ 28.04 52-Week Range
Ticker Information

Ticker

ARVN

Company Name

ARVINAS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ARVINAS INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ARVN - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 609.3M$ -72.6M-11.92%
3/31/2025$ 660.1M$ -46.6M-7.06%
12/31/2024$ 561.7M$ -198.9M-35.41%
9/30/2024$ 586M$ -308.6M-52.66%
6/30/2024$ 600.2M$ -323.4M-53.88%
3/31/2024$ 609.7M$ -354.8M-58.19%
12/31/2023$ 660M$ -367.3M-55.65%
9/30/2023$ 457.2M$ -295.4M-64.61%
6/30/2023$ 463.6M$ -297.6M-64.19%
3/31/2023$ 511M$ -301M-58.9%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ARVINAS INC's latest trailing twelve months (TTM) ROE stands at -48.18%.
  • Over the past 5 years, ARVINAS INC's average ROE has been -39.06%.
  • The median ROE for ARVINAS INC during this period was -38.03%
  • ARVINAS INC reached its highest ROE over the past 5 years at -7.06%.
  • The lowest ROE recorded by ARVINAS INC in the same timeframe -64.61%

ARVINAS INC's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
RIGL : RIGEL PHARMACEUTICALS INC 119.39%MRVI : MARAVAI LIFESCIENCES HOLDINGS INC -73.24%KROS : KEROS THERAPEUTICS INC 2.66%SNDA : SONIDA SENIOR LIVING INC -68.77%CSTL : CASTLE BIOSCIENCES INC -2.08%RGNX : REGENXBIO INC -82.17%XNCR : XENCOR INC -27.58%ANGO : ANGIODYNAMICS INC -17.95%NKTR : NEKTAR THERAPEUTICS -KURA : KURA ONCOLOGY INC -64.54%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for ARVINAS INC is calculated as follows: Net Inc. Cmn. [ $ -98.83M ] / Equity [ $ 205.12M ]
(=) ROE [ -48.18% ]

ARVN - Return on Equity, Last 5 years

-64.61%

Minimum

Sep 30, 2023

-7.06%

Maximum

Mar 31, 2025

-39.06%

Average

-38.03%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.14K
min-66.79%
max73.25%
average1.51%
median6.45%
std22.67%